About Medreich Limited
Data last updated:
Medreich Limited is a public limited company based in Bangalore, Karnataka, India, a subsidiary of Meiji Seika Pharma Co., Ltd. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 August 1973 and has been in existence for over 53 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24232KA1973PLC002383. Its GSTIN is 29AABCM1458Q1ZW (Karnataka). The company holds 6 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹160.5 Cr and a paid-up capital of ₹40.16 Cr. It was formerly known as Sterilab Private Limited and Medreich Sterilab Private Limited. It is led by directors including Pankaj Garg (Managing Director) and Tsutomu Yamada.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Medreich House No.12/8 Saraswathi Ammal Street Maruthi Seva Nagar, Bangalore, Karnataka, India – 560033.
As per the financials filed for FY 2024, the company reported a revenue of ₹1,604.4 Cr, a growth of 8% compared to the previous year. For the same year it recorded a net profit of ₹226.55 Cr (net margin 14.1%) and EBITDA of ₹294.66 Cr (EBITDA margin 18.4%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 9% over five years.
The company has about 1,833 employees on its provident fund (EPFO) records. Its group structure includes 2 subsidiaries and 1 joint venture.
The company is associated with 1 brand: Medreich. As per MCA filings, the company has satisfied charges of ₹662.34 Cr on record. Court records list 54 cases involving the company, including 29 filed by the company and 25 filed against it; 10 cases are pending. The company has 1 deal on record (1 secondary share transfer); the latest was in June 2015. The company has 3 MSME Form 1 returns on record between 2019 and 2024, listing 16 overdue payments to 8 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website medreich.com.
Company details
Name history
Medreich has undergone 4 name changes throughout its history. The current legal name is Medreich Limited.
| Company Name | Status |
|---|---|
| Medreich Limited | Current |
| Sterilab Private Limited | Previous |
| Medreich Sterilab Private Limited | Previous |
| The Mukund Insurance Co. Limited | Previous |
| The Prakash Insurance Co. Limited | Previous |
Contact details
Medreich Limited's registered office is in Bangalore, Karnataka. Its website is medreich.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressMedreich House No.12/8 Saraswathi Ammal Street Maruthi Seva Nagar, Bangalore, Karnataka, India – 560033
- IndustryPharma, Drug Formulation & Development, Pharma Contract R&D
To see the full contact details of Medreich Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Medreich operates one associated brand: Medreich. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical contract manufacturing and development services are provided. | medreich.com |
Financials of Medreich Limited
FY 2025 filings availableMedreich Limited reported revenue of ₹1,604.4 Cr (up 8% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 9% over five years, including 8% growth in the latest year. EBITDA rose 10% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹1,604.4 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹294.66 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹226.55 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 18.4% | ||||
| Net Profit Margin | 14.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medreich Limited, buy the company report.
Board of directors of Medreich Limited
Medreich has 6 current directors and 42 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Tsutomu Yamada | Director | 31 Jul 2023 | 3 Years 2 Months | Current |
| Pankaj Garg | Managing Director | 31 Jul 2015 | 11 Years 2 Months | Current |
| Yasuhiro Nakagiri Also directs: Adcock Ingram Limited, Adcock Ingram Pharma Private Limited | Additional Director | 09 May 2024 | 2 Years 5 Months | Current |
| Misa Hirose | Director | 28 Jun 2022 | 4 Years 3 Months | Current |
| Kenshi Murase Also directs: Adcock Ingram Limited, Adcock Ingram Pharma Private Limited | Director | 02 Jul 2018 | 8 Years 3 Months | Current |
| Ryoji Kikuchi | Director | 16 Jul 2021 | 5 Years 3 Months | Current |
Auditor
Medreich Limited is audited by S.R. Batliboi & Associates LLP for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S.R. Batliboi & Associates LLP | FY 2024 | 101049W/E300004 |
Shareholding
The shareholding of Medreich Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Medreich Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 11 Apr 2022 | 100560245 | Standard Chartered Bank | ₹1.7 Cr | Satisfied | |
| 13 May 2019 | 100266584 | Standard Chartered Bank | ₹100 Cr | Satisfied | |
| 11 Oct 2013 | 10454357 | Standard Chartered Bank | ₹100.8 Cr | Satisfied | |
| 13 Aug 2013 | 10443792 | The Hongkong & Shanghai Banking Corporation Limited | ₹30 Cr | Satisfied | |
| 13 Aug 2013 | 10447319 | The Hongkong and Shanghai Banking Corporation Limited | ₹75.6 Cr | Satisfied |
To see the full charge records of Medreich Limited, buy the company report.
Total charge records: 11 View all charges
Deals & funding
Medreich Limited has 1 deal on record (1 secondary share transfer); the latest was in June 2015.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jun 2015 | Secondary share transfer | Undisclosed | Buyer: Thai Meiji Pharmaceuticals Co.., Ltd, Meiji Pharma Spain, S.a, Meiji Pharma Korea Co...Ltd, an individual Seller: Med Holdings (Uk) Limited, Nokha Trading Private Limited , 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Medreich Limited has 54 court cases on record: 29 filed by Medreich, 25 filed against it. 10 cases are pending and 44 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 38 | 18 | 6 |
| District courts | 15 | 7 | 4 |
| Supreme Court | 1 | 0 | 0 |
Cases on record (5 of 54)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, TELANGANA | Writ petition | Filed by the company against M/S. A.P. State Non-Resident Indian Investment Corpn. Ltd (Anrich) and 3 others | Pending |
| Allahabad High Court | Court case (A227) | Filed against the company by Jamp India Pharmaceuticals Private Limited | Disposed |
| Allahabad High Court | Court case (A227) | Filed against the company by M/S Gracure Pharmaceuticals Limited | Disposed |
| Allahabad High Court | Court case (A227) | Filed by the company against Jubilant Generics Limited and 3 Others and 3 others | Disposed |
| High Court, UTTARPRADESH | Court case (COPL) | Filed against the company by Jamp India Pharmaceuticals Private Limited | Disposed |
To see the full case history of Medreich Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Medreich Limited was last rated by Icra on 31 Mar 2022.
| Rating agency | Rated on | Rating |
|---|---|---|
| Icra | 31 Mar 2022 |
To see the full credit ratings and regulatory alerts of Medreich Limited, buy the company report.
MSME payment delays
Medreich Limited has 3 MSME Form 1 returns on record between 2019 and 2024, listing 16 overdue payments to 8 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 8)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Parekhplast India Limited | |||
| Labsupplies India Private Limited | |||
| Ami Polymer Private Limited | |||
| an individual supplier | |||
| Electrolab (India) Private Limited |
To see the full MSME payment records of Medreich Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Medreich has 2 subsidiary companies and 1 joint venture. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Genovo Development Services Limited | U24230KA2008PLC046164 | |
| Medreich Lifecare Limited | U24230KA2008PLC062782 |
To see the full group structure of Medreich Limited, buy the company report.
Employees & EPFO
Medreich Limited has a workforce of 1,833 employees on its EPFO records as of Apr 01, 2024, across 4 active EPFO establishments.
GST
Medreich has 6 GST registrations: 2 active and 4 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AABCM1458Q1ZW | Karnataka | Active | 01 Jul 2017 |
| 36AABCM1458Q1Z1 | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Medreich Limited, buy the company report.
Recent activity
Medreich Limited has 47 board changes on record since 2008: 8 appointments and 39 cessations. The latest: Yasuhiro Nakagiri was appointed as Additional Director on 09 May 2024.
66 earlier events are in the company report.
Frequently asked questions
Medreich is an active public limited company based in Bangalore, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 August 1973 (53+ years old) and is registered under CIN U24232KA1973PLC002383.
Medreich has 6 current directors:
- Pankaj Garg - Managing Director
- Tsutomu Yamada - Director
- Yasuhiro Nakagiri - Additional Director
- Misa Hirose - Director
- Kenshi Murase - Director
- Ryoji Kikuchi - Director
The latest financial statements of Medreich on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Medreich is 29AABCM1458Q1ZW, registered in Karnataka. The company has 6 GST registrations in all, of which 2 are active and 4 are cancelled or inactive. Other active GSTINs include 36AABCM1458Q1Z1 (Telangana).
The CIN (Corporate Identification Number) of Medreich is U24232KA1973PLC002383. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medreich has 54 court cases on record: 29 filed by the company and 25 filed against it. 10 are pending. Most are in the high courts.
Medreich was incorporated on 16 August 1973, making it 53+ years old. It is registered with the Registrar of Companies, Bangalore.
Medreich has 1 deal on record (1 secondary share transfer); the latest was in June 2015.
Yasuhiro Nakagiri was appointed as Additional Director on 09 May 2024. Tsutomu Yamada ceased to be Additional Director on 28 Sep 2023. Tsutomu Yamada was appointed as Director on 31 Jul 2023. Medreich has 47 board changes on record in total.
Medreich has 3 MSME Form 1 returns on record between 2019 and 2024, listing 16 overdue payments to 8 micro and small suppliers. The latest return was filed on 30 Apr 2024.
Medreich can be reached through the website medreich.com. Its registered office is in Bangalore, Karnataka, India.